Showing results (261-270 of 281) with videos related to

Sort By:
Pageof 29
Oncology|October 20, 2024
Tissue and Imaging Biomarkers of Response to Neoadjuvant Nivolumab or Nivolumab plus Ipilimumab in Patients with Resectable Hepatocellular CarcinomaMichael LaPelusa, Shadi Chamseddine, Hop Sanderson Tran Cao, et al.
Human Vaccines & Immunotherapeutics|March 14, 2023
Effectiveness of the pre-Omicron COVID-19 vaccines against Omicron in reducing infection, hospitalization, severity, and mortality compared to Delta and other variants: A systematic reviewPradipta Paul, Ahmed El-Naas, Omar Hamad, et al.
Infection and Drug Resistance|January 27, 2025
Rates of Multidrug-Resistant Gram-Negative Bacterial Infections in Hospitalized Non-Immunocompromised Pediatric Patients: A 9-Year Retrospective Study at a Lebanese Tertiary Medical CenterRamia Zakhour, Sarah Khafaja, Rawan Korman, et al.
Frontiers in Cellular and Infection Microbiology|January 23, 2026
Epidemiologic characteristics and clinical outcomes of respiratory syncytial virus in hospitalized care in Lebanon: a prospective observational studySarah Khafaja, Sarah Merhi, Stephanie Damaj, et al.
Cancer Biomarkers : Section a of Disease Markers|September 13, 2024
Circulating tumor DNA (ctDNA) as a biomarker of response to therapy in advanced Hepatocellular carcinoma treated with NivolumabYehia I Mohamed, Sunyoung S Lee, Tarik Demir, et al.
The Lancet. Diabetes & Endocrinology|May 11, 2020
Bariatric and metabolic surgery during and after the COVID-19 pandemic: DSS recommendations for management of surgical candidates and postoperative patients and prioritisation of access to surgeryFrancesco Rubino, Ricardo V Cohen, Geltrude Mingrone, et al.
BMJ Global Health|May 16, 2020
Safe management of bodies of deceased persons with suspected or confirmed COVID-19: a rapid systematic reviewSally Yaacoub, Holger J Schünemann, Joanne Khabsa, et al.
Cancer|March 12, 2024
PEC-PRO: A new prognostic score from a series of 87 patients with localized perivascular epithelioid cell neoplasms (PEComas) treated with curative intentJustine Gantzer, Maud Toulmonde, François Severac, et al.
American Journal of Blood Research|April 13, 2016
A nationwide non-interventional epidemiological data registry on myelodysplastic syndromes in LebanonZaher K Otrock, Nabil Chamseddine, Ziad M Salem, et al.
Medrxiv : the Preprint Server for Health Sciences|March 11, 2024
T cell and autoantibody profiling for primary immune regulatory disordersEmily M Harris, Sarah Chamseddine, Anne Chu, et al.
Pageof 29